Mark Horrigan

Loading... 2 0 20 0 false
Credit Name
Mark Horrigan
Full Name
Horrigan, Mark
 
Department
 
Loading... 3 0 20 0 false

Publications

Results 21-29 of 29 (Search time: 0.015 seconds).

Publication YearTitleAuthor(s)
2115-May-2020Meta-analysis Comparing Valve-In-Valve Transcatheter Aortic Valve Implantation With Self-Expanding Versus Balloon-Expandable Valves.Hamilton, Garry W ; Koshy, Anoop N ; Fulcher, Jordan ; Tang, Gilbert H L; Bapat, Vinayak; Murphy, Alexandra C ; Horrigan, Mark ; Farouque, Omar ; Yudi, Matias B 
226-Sep-2019Retrospective validation of the REVEAL 2.0 Risk Score with the Australian and New Zealand Pulmonary Hypertension Registry Cohort.Anderson, James J; Lau, Edmund M; Lavender, Melanie; Benza, Raymond; Celermajer, David S; Collins, Nicholas; Corrigan, Carolyn; Dwyer, Nathan; Feenstra, John; Horrigan, Mark ; Keating, Dominic; Kermeen, Fiona; Kotlyar, Eugene; McWilliams, Tanya; Rhodes, Bronwen; Steele, Peter; Thakkar, Vivek; Williams, Trevor; Whitford, Helen; Whyte, Kenneth; Weintraub, Robert; Wrobel, Jeremy P; Keogh, Anne; Strange, Geoff
39-Aug-2019Rare cause of pulmonary hypertension - pulmonary tumour thrombotic microangiopathy.O'Brien, Joseph M; Jones, Nicholas ; Horrigan, Mark ; Al-Kaisey, Ahmed M
4Dec-2018Feasibility of using ultra-low pulse rate fluoroscopy during routine diagnostic coronary angiography.Badawy, Mohamed Khaldoun; Scott, Matthew; Farouque, Omar ; Horrigan, Mark ; Clark, David J ; Chan, Robert K 
528-Feb-2017Improving Guideline Compliance in Australia With a National Percutaneous Coronary Intervention Outcomes Registry.Eccleston, David; Horrigan, Mark ; Rafter, Tony; Holt, Geoffrey; Worthley, Stephen G; Sage, Peter; Whelan, Alan; Reid, Christopher; Thompson, Peter L
614-Sep-2016The receptor for advanced glycation end products (RAGE) is associated with persistent atrial fibrillationLancefield, Terase F; Patel, Sheila K ; Freeman, Melanie; Velkoska, Elena; Wai, Bryan; Srivastava, Piyush M ; Horrigan, Mark ; Farouque, Omar ; Burrell, Louise M 
71-Jul-2016Management of patients ≥85 years of age with ST-elevation myocardial infarctionYudi, Matias B ; Jones, N ; Fernando, Dharsh; Clark, David J ; Ramchand, Jay ; Jones, Elizabeth F ; Dakis, R; Johnson, Douglas F; Chan, Robert K ; Islam, Amirul; Farouque, Omar ; Horrigan, Mark 
81-Jul-2009Advances in percutaneous treatment for adult valvular heart disease.Wong, M C G; Clark, David J ; Horrigan, Mark ; Grube, E; Matalanis, George ; Farouque, Omar 
912-Oct-2005What is the best contemporary treatment for in-stent restenosis?Barlis, Peter; Horrigan, Mark ; Chan, Robert K ; Ajani, Andrew E; Proimos, George; Schumer, Wendy A; van Gaal, William J; Rowe, Michael; Eccleston, David; Yan, Bryan B P; Mun Cheong, Yu; Oliver, Les E; Clark, David J